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Abstract 
Keratoconus associated with myelinated retinal nerve fibers is not frequent and the 
relationship between the two pathologies is difficult to explain, therefore studies and 
further investigation are required. The etiology of each condition may suggest the role 
of genetic factors. Follow-up is important to evaluate the progression of keratoconus 
and myelination. Here we describe the unusual coexistence of keratoconus and 
ipsilateral myelinated retinal nerve fiber layer and, for the first time, the corneal 
cross-linking treatment in this condition. 
Introduction 
Keratoconus is an idiopathic, progressive, non-inflammatory ectasia of the lower 
central cornea [1]. The prevalence of keratoconus ranges from 50 to 230 in 100,000 [2]. Its 
cause is unknown, although metabolic/chemical changes have been documented [3, 4]. 
Genetic factors may play an important role, as indicated by the association of keratoconus 
with genetic syndromes and gene mapping studies [5–9]. 
Keratoconus has been associated with macular coloboma [10], Leber’s congenital 
amaurosis [11], retinal aplasia [12], cone-rod dystrophy [13], central serous 
chorioretinopathy [14], and rarely myelinated retinal nerve fibers [15]. Myelination, 
which occurs in 1% of the population [16, 17], normally terminates shortly after birth 
at the level of the lamina cribrosa. It seems to be due to anomalous distribution of 
oligodendroglia within the retina [17]. Retinal myelination is observed as an  
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asymptomatic, isolated finding following routine examination. It is usually 
non-progressive, although there are two cases in which progression has been confirmed 
[18, 19]. 
Case Report 
A 39-year-old woman presented with a diagnosis of stage II keratoconus in the right eye and 
stage I keratoconus in the left eye. The patient, characterized by eutocic childbirth, was on no general 
or local medication and had no history of any systemic illness or trauma, except for the detection of 
peripapillary myelinated retinal nerve fibers and amblyopia in her right eye during childhood. Medical 
history was negative for eye rubbing and/or allergic conjunctivitis.  
Her best corrected visual acuity was 20/30 in the right eye, with refractive error of –1.50–2.50 × 90, 
and 20/20 with –1 × 80 in the left eye. Axial lengths were 24.35 mm in the right eye and 24.20 mm in the 
left eye. Slit-lamp biomicroscopy revealed corneal steepening in the inferior paracentral area in the right 
eye, much more evident than in the left one, and absence of Vogt’s striae and Fleisher’s ring in both 
eyes. The fundus oculi demonstrated extensive papillary and peripapillary myelination in the right eye 
only (fig. 1): the patch was located at the superior-inferior sectors of the optic nerve head and along the 
superior-inferior retinal vascular arcades masking the lower vessels. Corneal topography (Eye Top CSO, 
Italy) showed markedly irregular astigmatism and inferior-superior asymmetry in the right eye (fig. 2) 
and a focal inferonasal steepening in the left eye (fig. 3). The OCT pachymetry map scans were acquired 
with a high-speed anterior segment OCT prototype (Carl Zeiss Meditec Inc., Dublin, Calif., USA). The 
right eye was scanned and the pachymetry map was calculated. The thinnest point was 435 μm in the 
range of 2–5 mm. Our patient showed indications for treatment with the cross-linking in her right eye.  
Thirty minutes before the procedure, 2% pilocarpine drops were instilled to reduce the amount of 
light rays potentially harmful to the lens and retina. After topical anesthesia with two applications of 
lidocaine hydrochloride drops 4% and benoxinate hydrochloride 0.2% (oxybuprocaine hydrochloride), 
the corneal epithelium was abraded in a central, 9-mm-diameter area, using an Amoil brush. Before 
beginning ultraviolet A (UVA) irradiation, photosensitizing riboflavin (vitamin B2) 0.1% solution 
(10 mg riboflavin-5-phosphate in 10 ml dextran 20% solution) was applied to the cornea every minute 
for 15 min to achieve adequate penetration of the solution. After the removal of the corneal epithelium 
and the application of riboflavin, the cornea underwent low-dose (3 mW/cm
2) irradiation with UVA 
lasting 30 min; in the meantime, the use of riboflavin was repeated every 2.5 min. After exposure to 
UVA the eye was medicated with antibiotic, mydriatic, anti-inflammatory eye drops and finally a 
bandage contact lens was inserted, which was removed at the follow-up visit after 4 days once epithelial 
healing was complete. Postoperatively, topical levofloxacin was given 4 times daily for 10 days, 
flurbiprofen sodium drops 3 times daily for 20 days and hyaluronate sodium drops 0.15% 6 times daily 
for 45 days. In addition, our patient received oral aminoacid supplements for 10 days. 
During the 6-month follow-up period, no side effect was observed. Biomicroscopic examination 
detected no abnormalities of corneal transparency; the fundus oculi was unchanged from the 
pre-operative state. Refractive and topographic control showed stabilization of the progression of 
keratoconus. In particular were evaluated best corrected visual acuity, apical keratometry, mean Ks, 
apical curvature gradient and inferior-superior index, which were comparable to preoperative data. 
Discussion 
To the best of our knowledge, corneal cross-linking for the treatment of keratoconus 
has not been previously reported in a patient with the coexistence of abnormalities in the 
ipsilateral posterior segment such as myelinated retinal nerve fiber layer. An association 
between idiopathic keratoconus and myelinated retinal nerve fiber layer has been 
reported in the literature [17], although it does not provide an estimate of incidence. The 
onset of keratoconus occurs during puberty and the disorder progresses until the third to 
fourth decade of life, when it usually arrests [2]. On the other hand, myelinated retinal  
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nerve fibers are developmental anomalies that usually appear as congenital and stationary 
lesions, rarely described as being acquired or progressive [19]. 
In the case of our patient, the diagnosis of keratoconus was made at the age of 27 years, 
whereas the detection of abnormal fundus examination dates back to her childhood. The 
patient also reported vision worsening since school age. The decision to refer the patient 
to treatment with cross-linking was also derived from the stability of objective 
examination of the ocular fundus evaluated by comparing the retinal performed in time. 
Another aspect we considered was the poor visual acuity of the woman’s right eye since 
childhood. 
Schmidt et al. [20] proposed that myelinated fibers could blur retinal images and 
induce visual deprivation. Straatsma et al. [17] found that 10% of patients with 
myelinated nerve fibers have myopia, amblyopia and strabismus. The cause of amblyopia 
in patients with myelinated retinal nerve fibers is a matter of controversy. Some authors 
believe in an organic etiology and postulate that myelinated nerve fibers result in 
elevation of the optic disc and disorganization of neural elements leading to amblyopia 
[21]. In contrast, others believe that myelination does not cause organic visual loss [15]. 
An estimated amblyopia prevalence from 2 to 3%, which is mainly an anisometropic 
amblyopia, and a 0.9% prevalence of unilateral nerve fiber layer myelination, would lead 
to believe the combination of these findings is more frequent [16]. In our case we can 
exclude anisometropic amblyopia as proved by the calculation of biometrics in the two 
eyes. 
In this case, keratoconus treatment was also intended to maintain stable visual acuity 
in the right eye, already reduced in relation to the presence of ipsilateral myelinated 
retinal nerve fibers. Cross-linking of collagen with riboflavin 0.125% UVA is 
recommended for all forms of keratoconus in refractive stage (I and II) that are negatively 
progressing, that is to say keratoconus with a clinically, topographically, pachymetry-
documented worsening over the last 6 months. It is for such considerations that our 
patient was subjected to treatment. 
Since the pilot study by Wollensak et al. published in January 2003 [22], there have 
been eight studies which have reported their efficacy results. The study methodology, in 
terms of inclusion and exclusion criteria, treatment parameters, outcome measures and 
analysis are very variable among the studies. All the studies have reported varying degrees 
of improvement in visual acuity, reduction in keratometry, with a progressive trend in 
improvement for the duration of follow-up, which was in some cases 3 years or longer. 
No major complications were noted, although some studies have claimed to have 
re-treated their non-responders [23]. 
The post-operative results obtained in our case are similar to those demonstrated by 
studies with a minimum follow-up of 6 months that indicate stabilization of progressive 
keratoconus after collagen cross-linking [24]. The progression of keratoconus and 
stability of ipsilateral myelination allowed corneal cross-linking in the right eye of our 
patient. Corneal cross-linking in our patient was found to be non-invasive, safe and 
effective. It was also important to verify the absence of postoperative changes in the 
fundus oculi, this being the first case of keratoconus treated in a patient with myelinated 
retinal nerve fiber. 
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Fig. 1. Funduscopic image of the right eye showing myelinated retinal nerve fibers (FF450 plus IR 
fundus camera, Carl Zeiss, Germany). 
 
 
 
Fig. 2. Summary of topographic maps of the right eye (CM02/CM-P02 Corneal Topographer, CSO, 
Scandicci, Italy). 
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Fig. 3. Summary of topographic maps of the left eye; steepening in power map in the inferonasal 
quadrant. 
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